Given that DSBs represent the most biologically significant lesions induced by IR, and defective DSB repair confers cellular radiosensitivity, BRCA1/2-mutant cancer patients were hypothesized to derive substantial benefit from radiotherapy. Here, BRCA1 is linked to cancer.